Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Grifols S.A.

    NASDAQ: GRFS · Real-Time Price · USD
    10.57
    -0.15 (-1.40%)
    At close: Aug 18, 2025, 1:15 PM
    -1.40%
    Bid 10.56
    Market Cap 8.94B
    Revenue (ttm) 7.45B
    Net Income (ttm) 297.45M
    EPS (ttm) 0.52
    PE Ratio (ttm) 20.33
    Forward PE 9.51
    Analyst Hold
    Ask 10.57
    Volume 330,139
    Avg. Volume (20D) 983,743
    Open 10.63
    Previous Close 10.72
    Day's Range 10.49 - 10.63
    52-Week Range 6.19 - 11.14
    Beta 0.97

    About GRFS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol GRFS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for GRFS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts
    3 months ago
    +8.87%
    Grifols shares are trading higher after the compan... Unlock content with Pro Subscription
    8 months ago
    Grifols shares are trading lower after the company ended discussions with Brookfield Capital Partners regarding a potential acquisition.
    news image

    2 weeks ago · zacks.com

    New Strong Sell Stocks for July 31st

    CELZ, GRFS and WHR have been added to the Zacks Rank #5 (Strong Sell) List on July 31, 2025.

    news image

    2 months ago · zacks.com

    Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know

    Does Grifols (GRFS) have what it takes to be a top stock pick for momentum investors? Let's find out.

    news image

    2 months ago · zacks.com

    Is Grifols (GRFS) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

    news image

    2 months ago · zacks.com

    GRFS vs. STVN: Which Stock Is the Better Value Option?

    Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang fo...

    news image

    2 months ago · businesswire.com

    Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting

    NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 3% of Grifols S.A. (“Grifols” or the “Company”) (BME: GRF...

    news image

    2 months ago · reuters.com

    US court finds enough evidence to proceed with Grifols lawsuit against Gotham City

    A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols against short seller Gotham City Research, Grifols said in a statement on...

    news image

    2 months ago · zacks.com

    ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?

    At current levels, GRFS scores over ADMA with cheaper valuation, a broad portfolio, and strong EPS growth estimates despite the latter's robust Asceniv-driven momentum.

    news image

    2 months ago · seekingalpha.com

    Grifols: If This Works Out, It Has Massive Upside

    Grifols offers compelling long-term upside, with potential returns exceeding 200% as the company recovers and grows earnings. Recent Q1 2025 results confirm strong operational recovery: top-line growt...

    Add to Watchlist